CDMO - חוב כולל להון Avid Bioservices Inc

Avid Bioservices, Inc. (CDMO) generates revenue by providing its manufacturing facilities to external developers of biological products. However, reduced startup investment and equipment costs are weighing on profitability. Qualified engineers, operating in strict accordance with quality regulations, ensure business stability. The total debt-to-equity ratio stands at 4.27, as clearly illustrated by this chart of share price quotes.

This ratio reflects the proportion of borrowed funds to equity, measuring the degree of financial leverage and the company's dependence on external borrowing. By analyzing changes in the business's leverage ratio, an investor assesses the risk of balance sheet overload, which is critical for Avid Bioservices, Inc. (CDMO) during the large-scale expansion of production capacities and the modernization of filling lines to clear the order backlog.